| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Dexcom, Inc. (DXCM) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. DXCM is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 331.7K | $19.43M | - | |
| VP | 118.7K | $6.95M | - | |
| VP | 111.2K | $6.51M | -1,700 | |
| VP | 105.2K | $6.16M | - | |
| VP | 68.7K | $4.03M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2023 | Regan Barry J.60 | EVP Operations | Sell | 2,213 | $106.12 | $234,843.56 | -3.6% | +12.3% | +14.5% | |
| Jan 30, 2023 | Sayer Kevin R62 | President CEO And Chairman Of | Sell | 56,844 | $106.15 | $6,034,123.08 | -7.1% | +12.3% | +14.5% | |
| Jan 23, 2023 | Pacelli Steven Robert57 | EVP Managing Director Dexcom V | Sell | 412 | $107.86 | $44,438.32 | -0.3% | +16.4% | +19.5% | |
| Jan 20, 2023 | Sayer Kevin R62 | President CEO And Chairman Of | Sell | 45,607 | $105.75 | $4,822,871.84 | -9.7% | +13.3% | +18.0% | |
| Dec 23, 2022 | Pacelli Steven Robert57 | EVP Managing Director Dexcom V | Sell | 412 | $112.57 | $46,378.84 | -0.3% | +2.7% | +9.6% | |
| Dec 8, 2022 | Flynn Paul R47 | EVP Global Revenue | Sell | 8,988 | $123.50 | $1,110,018.00 | -13.9% | -8.1% | -4.6% | |
| Nov 21, 2022 | Sylvain Jereme M65 | EVP Chief Financial Officer | Sell | 2,400 | $112.62 | $270,288.00 | -3.4% | +1.2% | -3.3% | |
| Sep 1, 2022 | Dolan Matthew Vincent63 | SVP Corporate Strategy-develop | Sell | 5 | $81.63 | $408.15 | - | +40.0% | +22.6% | |
| Aug 23, 2022 | Pacelli Steven Robert57 | EVP Managing Director Dexcom V | Sell | 1,000 | $84.21 | $84,210.00 | -0.7% | +34.7% | +24.8% | |
| Jul 25, 2022 | Pacelli Steven Robert57 | EVP Managing Director Dexcom V | Sell | 1,000 | $83.07 | $83,070.00 | -0.7% | +19.8% | +57.3% |